NIH begins clinical trial of hydroxychloroquine, azithromycin for COVID-19 treatment
Editor's Note The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin. The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2…
An agile, data-driven strategy for post-COVID-19 OR management
Editor's Note As states begin to ease restrictions imposed by COVID-19, physicians, nurse leaders, and administrators face a momentous challenge in resuming elective surgical procedures. Cincinnati Childrenโs Hospital Medical Center developed a model that made best use of available data (eg, case logs, forecasts, etc). Adoption of an agile methodologyโa…
CDC posts updated point-of-care testing guidelines for COVID-19
Editor's Note The Centers for Disease Control and Prevention on May 12 posted updated point-of-care (POC) testing biosafety guidelines for COVID-19. The update includes guidance for: use of instruments in a location associated with a current Clinical Laboratory Improvement Amendments certificate site- and activity-specific risk assessment proper staff training adherence…
Readying your SPD for a post-COVID world
Editor's Note While responding to demands of the COVID-19 pandemic, perioperative leaders also are busy preparing staff and departments for life after the initial shock subsides. Chief among their preparations are strategies to address the increased demand for surgery because of postponement of elective and nonessential surgical procedures. The sterile…
California pharmacists to begin testing patients for COVID-19
Editor's Note On May 12, California's Governor Gavin Newsom announced that California pharmacists will be allowed to collect specimens and order COVID-19 tests. Specimens will be are processed at public health, university, or commercial labs. The move is an effort to increase the stateโs testing capacity as it modifies its…
Provider burnout, fatigue during COVID-19 pandemic
Editor's Note This article from Houston Methodist Hospital and Texas A&M University researchers shares the lessons learned by an interdisciplinary team of ICU healthcare providers and their experiences of occupational fatigue and burnout as a result of the COVID-19 pandemic. The researchers documented four major areas of stress with the…
FDA accelerates development of COVID-19 prevention, treatment options
Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…
University of Kentucky researchers studying COVID-19 immunity
Editor's Note The University of Kentucky (UK) announced May 11 that researchers have begun antibody testing that will help to understand what immunity to COVID-19 really means. Several research labs within the UK College of Medicine and Pharmacy will be testing antibodies of recovered COVID-19 patients to see how long…
CMS releases proposed inpatient payment rule for FY 2021
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…
AI diagnostic predicts COVID-19 without testing
Editor's Note In this study, researchers at the Massachusetts General Hospital, Boston; Kingโs College, London; and health science company Zoe Global, Accra, Ghana; developed an artificial intelligence (AI) diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. The researchers analyzed data from 2,618,862 people…